BackChembio Diagnostics Overview

Chembio Diagnostics Accounts Payable

Track Chembio Diagnostics's accounts payable ($3.3M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Accounts Payable
$3.34M
56.84% YoYΔ $-4.40M vs prior year quarter

Peer average

Loading

Chembio Diagnostics Accounts Payable History

Loading

Chembio Diagnostics vs. peers: Accounts Payable Comparison

Loading

Chembio Diagnostics Accounts Payable Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Chembio Diagnostics (CEMI) FAQ

As of the most recent data (December 2022), CEMI shows a accounts payable of $3.3M. That compares with $7.7M in the prior-year period — down 56.8% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, CEMI's accounts payable is now $3.3M (was $7.7M) — a 56.8% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Chembio Diagnostics is outperforming or lagging.

Tracking CEMI's accounts payable over time shows whether Chembio Diagnostics is scaling, shrinking, or reshaping that part of the business. The current reading is $3.3M That compares with $7.7M in the prior-year period — down 56.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this accounts payable page, Stockcircle has Chembio Diagnostics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect accounts payable (currently $3.3M) with ownership activity and broader fundamentals.

Chembio Diagnostics's accounts payable is $3.3M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.